Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandoned, accessible, ASCO, Atlantic, auto, Automated, backup, bad, banc, beyslate, Bfarm, binding, BioPharma, boosted, Brian, brivanib, broaden, broker, BSC, buildup, buyback, carryback, CASTLE, chain, Chase, chiller, CHMP, chose, Cidron, cohort, Cologne, comfort, Commentary, confronted, Consiglio, cooling, correlated, correlation, corroborated, curtailment, dealer, decisionen, di, disability, driver, Dupont, EBITDA, efavirenez, elotuzumab, England, ERISA, EURIBOR, evidenced, exact, FGF, finite, FLEX, Frameworkissued, gas, gene, geography, glucose, grace, grown, guarantor, Hexal, hierarchy, histology, hydrobromide, Ib, ibipinabant, IIIb, illegal, illegally, inaccuracy, inApotex, incidence, IND, inflammatory, inflow, interferon, IPO, IPRD, JIA, JPMCB, JPMorgan, KAI, knee, Kosan, lambda, Lancet, landmark, League, leverage, library, lithium, live, lived, McBride, medullary, Middlesex, milligram, monetization, monoline, movement, MTX, mutant, mutated, myeloma, necessitate, neurodegenerative, Nordic, Numico, NYAG, NYMEX, ofThe, ONGLYZA, Opportunistic, outflow, outpacing, PBO, PDL, pediatic, picture, postemployment, powder, preemption, psychosocial, Pty, Quotation, RAF, Ratiopharm, reconsider, refile, rehearingen, remission, renamed, reputation, resubmit, RET, retrofit, Rheumatism, RNA, rollforward, Royal, Russia, salicylatate, SCC, Score, SGLT, shutdown, SIMILAC, sleep, Society, Spirit, splitting, Stato, stemming, string, suffer, suggesting, surgery, Tanespimycin, taurocholate, theSampson, thyroid, tie, tolling, Tort, transparency, transparent, triple, turmoil, unadjusted, undergo, undergoing, understood, undetectable, undifferentiated, unobservable, unsecured, valproate, VEGF, viral, VTE, warranty, wave
Removed:
acetaminophen, achievable, adjustable, aforementioned, AJCA, anticipation, antidepressant, AQUACEL, argument, assertion, attributing, authorize, Barceloneta, Bari, bladder, bond, buying, call, carboplatin, chemotherapeutic, clearance, collected, collection, commingled, commit, computation, conditional, conjunction, consigned, consignment, conspiracy, copromoting, COUMADIN, Creation, debenture, decided, declining, deep, defer, defraud, delayed, depletion, distributed, document, DOJ, domestic, Dominican, dosing, DPA, DUODERM, eligibility, embolism, employ, EMSAM, equalization, ESTEEM, eventual, expandable, explore, Fabre, feature, flu, generation, headcount, hereto, Humacao, impracticable, lacked, MACT, marked, Marshall, Medicament, Michigan, mild, moderately, modern, MONOPRIL, muraglitazar, NATURA, necessarily, nefazodone, NPA, nullity, occurrence, occurring, opposed, organized, ostomy, OTN, oversee, packing, passively, Pierre, prospectively, prostate, put, rational, read, realign, registrational, remained, repatriation, reserve, retiree, retrospective, revaluation, revoked, satisfied, season, serzone, settling, shift, shown, skin, Somerset, steady, Stephen, Stockand, stocking, streamlining, subscription, systematic, tangible, tender, toddler, tranche, underfunded, undertook, unenforceable, unfunded, uninterrupted, University, unused, upward, USAO, vanlev, vinflunine, violation, warehousing, warfarin, wastewater, withdrew, wound
Filing tables
Filing exhibits
- 10-K Annual report
- 10 Form of Performance Shares Agreement for the 2009-2011 Performance Cycle
- 10 Form of Agreement
- 12 Statement Re Computation of Ratios
- 21 Subsidiaries of the Registrant
- 23 Consent of Deloitte & Touche
- 31 Section 302 Certification Letter
- 31 Section 302 Certification Letter
- 32 Section 906 Certification Letter
- 32 Section 906 Certification Letter
Related press release
BMY similar filings
Filing view
External links
EXHIBIT 12.
Computation of Earnings to Fixed Charges
Five Year Ratio of Earnings to Fixed Charges:
Dollars in Millions | 2008 | 2007 | 2006 | 2005 | 2004 | |||||||||||||||
Earnings | ||||||||||||||||||||
Earnings from continuing operations before income taxes and minority interest | $ | 5,471 | $ | 3,186 | $ | 2,085 | $ | 4,016 | $ | 3,911 | ||||||||||
Less: | ||||||||||||||||||||
Equity in net income of affiliates | 617 | 524 | 474 | 334 | 273 | |||||||||||||||
Income adjusted for equity income | 4,854 | 2,662 | 1,611 | 3,682 | 3,638 | |||||||||||||||
Add: | ||||||||||||||||||||
Fixed charges | 393 | 504 | 566 | 408 | 369 | |||||||||||||||
Distributed income of equity investments | 590 | 488 | 439 | 383 | 278 | |||||||||||||||
Pre-tax losses of equity investees | 17 | 12 | 10 | 9 | 3 | |||||||||||||||
Less: | ||||||||||||||||||||
Capitalized interest | (23 | ) | (27 | ) | (18 | ) | (9 | ) | (10 | ) | ||||||||||
Total Earnings | $ | 5,831 | $ | 3,639 | $ | 2,608 | $ | 4,473 | $ | 4,278 | ||||||||||
Fixed Charges | ||||||||||||||||||||
Interest and debt expense | $ | 310 | $ | 422 | $ | 498 | $ | 349 | $ | 310 | ||||||||||
Capitalized interest | 23 | 27 | 18 | 9 | 10 | |||||||||||||||
One-third of rental expense(1) | 60 | 55 | 50 | 50 | 49 | |||||||||||||||
Total Fixed Charges | $ | 393 | $ | 504 | $ | 566 | $ | 408 | $ | 369 | ||||||||||
Ratio of Earnings to Fixed Charges | 14.84 | 7.22 | 4.61 | 10.96 | 11.59 |
(1) | Rents included in the computation consist of one-third of rental expense which the Company believes to be a conservative estimate of an interest factor in its leases, which are not material. |
E-12-1